# FDA Inspection 1059921 - Biomat USA, Inc. - July 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/88ee4c1e-d39e-4966-bb4c-e447d6a7f126
Source feed: FDA_Inspections

> FDA Inspection 1059921 for Biomat USA, Inc. on July 25, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059921
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-07-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1252470 - 2025-02-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/667b3387-5af0-48d9-8be6-1cc16cacc52f)
- [FDA Inspection 1252470 - 2025-02-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/216f3a1a-2dc4-4f20-b7dd-875ef055b7a2)
- [FDA Inspection 872475 - 2014-03-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/18bc18dc-7ad2-401c-99e3-e05bf62aa9ee)
- [FDA Inspection 740512 - 2011-08-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/432d2c58-24cf-48b2-a255-662a58a79648)

Company: https://www.keypedia.com/companies/biomat-usa-inc/16ebf1f3-9d78-41cd-8f11-36b043b1ec88

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d